Lifeward announced that it will begin selling the AlterG family of products through its German sales organization, effective immediately. The announcement was made at today’s REHACARE 2024 conference in Dusseldorf, Germany, where the new AlterG NEO will be available for live demonstrations and purchase. The move adds the AlterG product line to the ReWalk Personal Exoskeleton in Lifeward’s German sales portfolio. The Company expects several financial benefits from selling directly, including greater revenue due to a more focused sales effort and higher margins with little incremental investment by utilizing its existing sales and support infrastructure in Germany. AlterG products have been available to customers in Germany since 2013 through a distribution arrangement with PHYSIOMED GROUP, formerly proxomed Medizintechnik. Under this existing contract, PHYSIOMED GROUP will continue to provide service and support to its existing base of nearly 500 customers in Germany and will continue to distribute AlterG units in parallel with the Lifeward team.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFWD:
- ReWalk Robotics finalizes name change to Lifeward
- ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
- Lifeward appoints Tansey as Consulting Director of Clinical Research
- Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
- Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury